Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders. - Wikidata - awgldk - TriplyDB

Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders.

Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders.

http://www.wikidata.org/entity/Q39355111

about

Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial.Sumatriptan does not change calcitonin gene-related peptide in the cephalic and extracephalic circulation in healthy volunteers Sumatriptan fast-disintegrating/rapid-release tablets in the acute treatment of migraine.Meeting acute migraine treatment needs through novel treatment formulations.Triptan nonresponders: do they exist and who are they?Biomarkers associated with migraine and their potential role in migraine management.The phenotype of migraine with unilateral cranial autonomic symptoms documents increased peripheral and central trigeminal sensitization. A case series of 757 patients.Neuropeptides as a Marker for Chronic Headache.Negative predictors of clinical response to triptans in patients with migraine.Sumatriptan inhibition of N-type calcium channel mediated signaling in dural CGRP terminal fibres.Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations.Novel Therapeutic Targets Against Spreading Depression.Increased VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine.Calcitonin gene-related peptide and migraine with aura: A systematic review.

P2860

Q36052140-BA036615-BEF0-4A2B-B5CC-8EFA0AA78514 Q36259595-32C43D73-B179-4565-AD17-9F650633326D Q36902009-571D1A20-6287-492A-B6DB-D2E2AB4A1333 Q37739586-9B7AE8B5-721B-4FED-AAAE-C86AAC297AD6 Q38096945-CB1C8F13-149D-456E-B7B5-A99CAA6EC603 Q38121110-FC398B63-A67D-4F6D-95CC-29CA0A808C3E Q38910565-6EDCF95E-36B6-4AFF-9A43-130E8476D8BB Q38915577-F4B7957A-33B4-4494-9EC4-A90078AEDF86 Q39720265-F62472A1-A587-434F-AF3E-EC48E597E894 Q42073244-3A717F8D-2A6A-4C93-87AD-05DBCB27506E Q42370565-B78F07FB-FA85-4B10-9872-624C383E17EB Q47787596-ED9D9B9F-320D-4D6C-81B9-92F4A6930721 Q48290660-0C852C29-6261-4CC5-9DB1-220FE7B4CC32 Q48366274-B391841B-5695-47A4-BB0B-EDA806CAD98B

P2860

Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders.

http://www.wikidata.org/entity/Q39355111

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Clinical-biochemical correlate ...... responders and non-responders.

@en

Clinical-biochemical correlate ...... responders and non-responders.

@nl

type

label

Clinical-biochemical correlate ...... responders and non-responders.

@en

Clinical-biochemical correlate ...... responders and non-responders.

@nl

prefLabel

Clinical-biochemical correlate ...... responders and non-responders.

@en

Clinical-biochemical correlate ...... responders and non-responders.

@nl

P1433

Q39355111-27042C5A-7E82-4DD5-9377-D6F6D5757E6F

P1476

Q39355111-7A58BF57-B966-4B8B-838F-71660BBA71CC

P2093

Q39355111-1139F3E7-CA2A-49D3-8501-4A105291B2A4

Q39355111-2DF2069F-E661-4E4E-81B7-BEF5B9056B02

Q39355111-5AB141FF-9045-431E-B3F1-A77C96721D71

Q39355111-A50B121C-1D92-4C40-B219-0CAF03F9022B

Q39355111-D46CE131-0B64-40FA-94E1-BE46744F873F

Q39355111-E4407FE7-2AE0-4EC1-99C6-EF694A243654

Q39355111-EE6E7FAA-0C86-41E9-8B7C-203D2227F9FE

P2860

Q39355111-07B49B8F-B05B-430A-891E-0C5950BF3FC9

Q39355111-2EF80FB6-7683-40CF-9538-6B40C9B34F2E

Q39355111-3C0273C5-A76C-4605-A7D8-350137A67D5B

Q39355111-3C2F4A2E-3EEA-4FF6-8CA3-5196AD30D4C9

Q39355111-3D4A73C8-79A1-466C-A16A-727BE655F79C

Q39355111-450C1258-B385-4345-B92E-A97378516B13

Q39355111-58E42A8E-65F4-45BE-8228-74D9083777AE

Q39355111-6033474E-C50C-4F40-A350-4D9976C499D5

Q39355111-7B73E346-21DB-48B0-8F13-6EC74E2B5CF1

Q39355111-7F46FEE5-323D-4E59-B01E-E675A0BA9EA3

P304

Q39355111-7B795341-9C99-4A75-BCEB-6588957E59D7

P31

Q39355111-98E1DFD3-C049-4FF4-9E61-39C2E41A474A

P356

Q39355111-BA6018B5-AC98-4E9B-869A-7CD75AD15F8B

P407

Q39355111-54029687-1D2A-4504-BEDE-4C2A1956166F

P433

Q39355111-677AD081-6FC3-41BA-9224-8A415CCA2A30

P478

Q39355111-42FE6412-B8C6-44BD-A609-3EC2BC0B8FFA

P50

Q39355111-FEF591FC-7392-448C-A57F-62B45C4BFFDC

P577

Q39355111-38905757-A46E-4F03-9860-78B00624193D

P698

Q39355111-59EFB12C-A22B-4A21-AE25-2F2E3CDDCD34

P921

Q39355111-E7D3F690-C174-426D-9285-75749029B4B8

P356

J.1468-2982.2005.01016.X

P1433

P1476

Clinical-biochemical correlate ...... responders and non-responders

@en

P2093

Alberti A

http://www.w3.org/2001/XMLSchema#string

Calabresi P

http://www.w3.org/2001/XMLSchema#string

Floridi A

http://www.w3.org/2001/XMLSchema#string

Maggioni F

http://www.w3.org/2001/XMLSchema#string

Rossi C

http://www.w3.org/2001/XMLSchema#string

Sarchielli P

http://www.w3.org/2001/XMLSchema#string

Zanchin G

http://www.w3.org/2001/XMLSchema#string

P2860

Advances in pharmacological treatment of migraine

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.

Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan.

Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.

Clinical benefits of early triptan therapy for migraine.

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.

Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B/1D receptor agonists.

Triptan nonresponder studies: implications for clinical practice.

Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severe.

Pain-free results with sumatriptan taken at the first sign of migraine pain: 2 randomized, double-blind, placebo-controlled studies.

P304

257-265

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1468-2982.2005.01016.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Luigi Alberto Pini

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16472331

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder